Fig 2.
(A) The prevalence of MS in subjects with obesity, visceral adiposity, or sarcopenia was higher than that in subjects without these parameters (P < 0.001 for all). (B) The prevalence of severe MS in subjects with obesity, visceral adiposity, or sarcopenia was higher than that in subjects without them (P < 0.001 for all). MS, metabolic syndrome.